WEST PHARMACEUTICAL SERVICES INC (WST) › Operating IncomeWEST PHARMACEUTICAL SERVICES INC (WST) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2008: $124.10M2009: $97.50M2010: $90.70M2011: $109.60M2012: $135.10M2013: $162.40M2014: $182.00M2015: $128.60M2016: $195.20M2017: $225.80M2018: $240.30M2019: $296.60M2020: $406.90M2021: $752.30M2022: $734.00M2023: $676.00M2024: $569.90M2025: $584.90M$584.90M2008Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$584.90M+2.6%2024$569.90M-15.7%2023$676.00M-7.9%2022$734.00M-2.4%2021$752.30M+84.9%2020$406.90M+37.2%2019$296.60M+23.4%2018$240.30M+6.4%2017$225.80M+15.7%2016$195.20M+51.8%2015$128.60M-29.3%2014$182.00M+12.1%2013$162.40M+20.2%2012$135.10M+23.3%2011$109.60M+20.8%2010$90.70M-7.0%2009$97.50M-21.4%2008$124.10M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share